Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro

Pharmazie

Volumn 63, Issue 5, 2008, Pages 372-376

  Buszman, Ewa ^a   Beberok, A ^a   Rozanska R ^a   Orzechowska, A ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DOPA; FLUPHENAZINE; MELANIN; POLYMER; TRIFLUOPERAZINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG BINDING; EYE TOXICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SCATCHARD PLOT; SWINE; TISSUE LEVEL; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; EYE; FLUPHENAZINE; INDICATORS AND REAGENTS; KINETICS; MELANINS; SPECTROPHOTOMETRY, ULTRAVIOLET; SWINE; TRIFLUOPERAZINE;

EID: 44349190187     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7663     Document Type: Article

References (34)

1. th ed., McGraw-Hill, International Edition, pp. 399-421.
2. Binns F, Chapman RF, Robson NC, Swan GA, Waggot A (1970) Studies related to the chemistry of melanins. Part VIII. The pyrrolecarboxylic acids formed by oxidation or hydrolysis of melanins derived from 3,4-dihydroxyphenetylamine or 3,4-dihydroxyphenylalanine. J Chem Soc: 1128-1134.
3. Buszman E (1994) Binding of drugs to melanin biopolymers in the presence of metal ions. Habilitation thesis, Medical University of Silesia, Katowice, Poland.
4. Buszman E, Różańska R (2003a) Interaction of chlorpromazine and fluphenazine with pig eye melanin in vitro. Ann Pol Chem Soc (Preliminary reports) 2: 265-268.
5. Buszman E, Różańska R (2003b) Interaction of thioridazine with ocular melanin in vitro. Acta Polon Pharm - Drug Research 60: 257-261.
6. Dayhaw-Barker P (2002) Retinal pigment epithelium melanin and ocular toxicity. Int J Toxicol 21: 451-454.
7. Delgado JN, Remers WA (1998) Textbook of Organic Medicinal and Pharmaceutical Chemistry. Lippincott-Raven Publishers, Philadelphia, New York, pp. 450-453.
8. Fornaro P, Calabria G, Corallo G, Picotti GB (2002) Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis. Doc Ophthalmol 105: 41-49.
9. Gadre DV, Talwar V, Gupta HC, Murthy PS (1998) Effect of trifluoperazine, a potential drug for tuberculosis with psychotic disorders, on the growth of clinical isolates of drug resistant Mycobacterium tuberculosis. Int Clin Psychopharmacol 13: 129-131.
10. Golbidi S, Moriuchi H, Irie T, Ghafghazi T, Hajhashemi V (2002) Involvement of calmodulin inhibition in analgesia induced with low doses of intrathecal trifluoperazine. Jpn J Pharmacol 88: 151-157.
11. Hollander DA, Aldave AJ (2004) Drug-induced corneal complications. Curr Opin Ophthalmol 15: 541-548.
12. Hu DN (2005) Photobiology of ocular melanocytes and melanoma. Photochem Photobiol 81: 506-509.
13. Hu DN, Savage HE, Roberts JE (2002) Uveal melanocytes, ocular pigment epithelium, and Muller cells in culture: in vitro toxicology. Int J Toxicol 21: 465-472.
14. Hull DS, Csukas S, Green K (1982) Chlorpromazine-induced corneal endothelial phototoxicity. Invest Ophthalmol Vis Sci 22: 502-508.
15. Hull DS, Csukas S, Green K (1983) Trifluoperazine: Corneal endothelial phototoxicity. Photochem Photobiol 38: 425-428.
16. Kalbitzer HR, Stehlik D (1979) On the analysis of competitive binding of various ligands to cooperative and independent binding sites of macromolecules. Z Naturforsch C 34: 757-769.
17. Larsson BS (1993) Interaction between chemicals and melanin. Pigment Cell Res 6: 127-133.
18. Leblanc B, Jezequel S, Davies T, Hanton G, Taradach C (1998) Binding of drugs to eye melanin is not predictive of ocular toxicity. Regul Toxicol Pharm 28: 124-132.
19. Marques LO, Lima MS, Soares BG (2004) Trifluoperazine for schizophrenia. Cochrane Database Syst Rev 1, CD 003545.
20. Mars U, Larsson BS (1999) Pheomelanin as a binding site for drugs and chemicals. Pigment Cell Res 12: 266-274.
21. Moorthy RS, Valluri S (1999) Ocular toxicity associated with systemic drug therapy. Curr Opin Ophthalmol 10: 438-446.
22. Nofsinger JB, Liu Y, Simon JD (2002) Aggregation of eumelanin mitigates photogeneration of reactive oxygen species. Free Radic Biol Med 15: 720-730.
23. Panzit M, Simon M, Weger M (2001) Persistenz stomaler Pigmentablagerungen in der Hornhaut beideits nach kurzzeitiger Therapie mit Antidepressiva bei einer Patientin. [Persistence of bilateral pigmentary deposits in stromal cornea in a woman after a brief treatment with antidepressants]. Klin Monatsbl Augenheilkd 218: 273-275.
24. th ed. The Pharmaceutical Press, London.
25. Persad S, Menon JA, Basu PK, Haberman HF (1986) Binding of imipramine, 8-methoxypsolaren and epinephrine to human blue and brown eye melanins. J Toxicol-Cut Ocular Toxicol 5: 125-132.
26. Rennie IG (1993) Clinically important ocular reactions of systemic drug therapy. Drug Safety 9: 196-211.
27. Roberts JE (2002) Screening for ocular phototoxicity. Int J Toxicol 21: 491-500.
28. Sharma S, Kaur H, Khuller GK (2001) Cell cycle effects of the phenothiazines: trifluoperazine and chlorpromazine in Candida albicans. FEMS-Microbiol Lett 199: 185-190.
29. To TQ (2000) Ocular toxicity of systemic medications: a case series. J Am Optom Assoc 71: 29-39.
30. Toler SM (2004) Oxidative stress plays an important role in pathogenesis of drug-induced retinopathy. Exp Biol Med (Maywood) 229: 607-615.
31. Toler SM (2005) Invited review: fluphenazine augments retinal oxidative stress. J Ocul Pharmacol Ther 21: 259-265.
32. Tolleson WH (2005) Human melanocyte biology, toxicology, and pathology. J Environ Sci Health 23: 105-161.
33. Walsh P (2001) Physician's Desk Reference Medical Economics Data Production Co., Montvale, NJ.
34. Wolf ME, Richer S, Berk MA, Mosnaim AD (1993) Cutaneous and ocular changes associated with the use of chlorpromazine. Int J Clin Pharm Ther Toxicol 31: 365-367.